Skip to main content
OpenTrials

Clinical trial condition

Locally Advanced Breast Cancer

Explore clinical trials studying Locally Advanced Breast Cancer. Study availability and eligibility vary by location and protocol.

50 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Locally Advanced Breast Cancer trial results

Completed

A Study of the Safety and Effectiveness of Irosustat When Added to an AI in ER+ve Locally Advanced or Metastatic Breast Cancer.

NCT01785992

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced Breast Cancer, +9 more
Locations
  • Mid Essex Hospital Services NHS Trust Chelmsford, United Kingdom
  • NHS Lothian Edinburgh, United Kingdom
  • NHS Greater Glasgow and Clyde Glasgow, United Kingdom
  • Royal Liverpool and Broadgreen University Hospital Liverpool, United Kingdom
View Trial Details
Completed

The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer

NCT00065325

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced Breast Cancer, +5 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Arcadia, California, United States
  • Research Site Fountain Valley, California, United States
  • Research Site Laverne, California, United States
View all 117 locations
View Trial Details
Completed

Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast Cancer

NCT00623233

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced Breast Cancer, +5 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fayetteville, Arkansas, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fresno, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Diego, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Longmont, Colorado, United States
View all 16 locations
View Trial Details
Active, Not Recruiting

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast Cancer

NCT03255577

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • BAPTIST ALLIANCE - MCI (Data Collection Only) Miami, Florida, United States
  • Memorial Sloan Kettering at Basking Ridge (Consent and Follow Up) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent only and Follow Up) Montvale, New Jersey, United States
View Trial Details
Active, Not Recruiting

A Study of the Efficacy, Safety and Pharmacokinetics of RPH-051 and Perjeta® in Combination With Trastuzumab and Docetaxel as the 1st Line Therapy in Patients With HER2-positive Breast Cancer

NCT07386938

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced Breast Cancer, +5 more
Locations
  • Regional Budgetary Healthcare Institution "Kursk Oncology Research and Clinical Center named after G.E. Ostroverhov" Kursk, Kursk Oblast, Russia
  • State Budgetary Healthcare Institution "Leningrad Regional Clinical Hospital" (SBHI "LOKH") Kuz'molovskiy, Leningradskaya Oblast', Russia
  • State Budgetary Healthcare Institution of Arkhangelsk Region "Arkhangelsk Clinical Oncology Dispensary" Arkhangelsk, Russia
  • Regional State Budgetary Healthcare Institution "Altai Regional Oncology Dispensary" Barnaul, Russia
View all 45 locations
View Trial Details
Active, Not Recruiting

Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy

NCT06449222

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced Breast Cancer, +7 more
Locations
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Stanford University School of Medicine - Stanford Cancer Institute (SCI) - Stanford Women's Cancer Center Palo Alto, California, United States
  • Saint John's Health Center - John Wayne Cancer Institute (JWCI) Santa Monica, California, United States
View all 31 locations
View Trial Details
Active, Not Recruiting

Onvansertib + Paclitaxel In TNBC

NCT05383196

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +15 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconness Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

The p53 Breast Cancer Trial

NCT02965950

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced Breast Cancer, +5 more
Locations
  • Haukeland University Hospital Bergen, Hordaland, Norway
  • St. Olavs Hospital Trondheim, Sør Trøndelag, Norway
  • Akershus University Hospital Lørenskog, Norway
  • Stavanger University Hospital Stavanger, Norway
View Trial Details

Related conditions